Publication: 192

Publication: 192

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 29 (10) 1373-1381

Year:: 2011
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:

Parents:: 469 743
Children:: None

Program:: TRP
Primary Committee:: Leuk Corr Sci
Sec. Committees:

Pharmas:
Grants:: CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, P30 CA016058, CA77658, CA129657, CA114725, CA31946

Corr. Author:
Authors:: Klaus H. Metzeler Kati Maharry Michael D. Radmacher Krzysztof Mrózek Dean Margeson Heiko Becker John Curfman Kelsi B. Holland Sebastian Schwind Susan P. Whitman Yue-Zhong Wu William Blum Bayard L. Powell Thomas H. Carter Meir Wetzler Joseph O. Moore Jonathan E. Kolitz Maria R. Baer Andrew J. Carroll Richard A. Larson Michael A. Caligiuri Guido Marcucci Clara D. Bloomfield

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-8525, CALGB-10201, CALGB-19808, CALGB-20202, CALGB-20502, CALGB-8461, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9665, CALGB-9720
Phases:: 1, 3, N/A

Keywords:: Hema4, Hema9, To2, To19, Original Reports, Hematologic Malignancies